3652 results for «231»
3652 results
Contrast-less PCI
22 Sep 2023 – From AICT-AsiaPCR 2023
Discover various techniques for minimizing contrast usage during PCI procedures in this session, and learn about precautionary measures to prevent contrast-induced nephropathy, procedural steps for limiting contrast in complex PCI, as well as the valuable role of OCT imaging in low-contrast complex PCI decision-making and optimization.
Complex STEMI cases
21 Sep 2023 – From AICT-AsiaPCR 2023
Dive into this STEMI session to gain valuable insights into managing critical scenarios, such as challenging primary PCI rescues, acute left main thrombosis, side branch occlusion, unexpected STEMI surprises, and more, all from real-world cases.
Navigating complex STEMI situations
21 Sep 2023 – From AICT-AsiaPCR 2023
Delve into a series of complex real-world STEMI cases and explore challenging scenarios in this session, such as a STEMI occurrence in a healthy adolescent, the complexities of post-CABG safety, and much more!
Learning - Percutaneous management of pulmonary embolism
22 Sep 2023 – From AICT-AsiaPCR 2023
Consult this session on percutaneous management of pulmonary embolism to learn about the indications for percutaneous pulmonary thrombectomy, to discover the techniques for performing this procedure, to gain insights into the various devices available, while exploring real-world case studies and staying updated on the latest clinical...
Top cases of AICT-AsiaPCR 2023
21 Sep 2023 – From AICT-AsiaPCR 2023
Discover the most intriguing cases featured at AICT-AsiaPCR 2023 in this session: from adrenaline surges to complex primary PCIs gone haywire, from CHIP protected PCI in AMICS to complex CTO of an anomalous RCA, dive into these real-world cases and gain valuable insights that expand your...
Exploring advancements in drug-coated balloons (DCB)
22 Sep 2023 – From AICT-AsiaPCR 2023
Delve into the world of drug-coated balloons (DCB) with these presentations: from unexpected developments to unveiling the complications that often go unnoticed, learn why tortuosity matters in seemingly straightforward cases and explore the revolutionary procedure of metal-less PCI.
Spontaneous coronary artery disease, INOCA, MINOCA in women
21 Sep 2023 – From AICT-AsiaPCR 2023
Consult this session to better understand the causes of myocardial infarction without obstructive disease (MINOCA), to revisit ischemia with no obstructive coronary atherosclerosis (INOCA), and to broaden your understanding of spontaneous coronary artery dissection (SCAD) beyond its association with pregnancy.
Next-gen complex interventional techniques and solutions
21 Sep 2023 – From AICT-AsiaPCR 2023
Join us in this session where experts delve into advanced techniques for complex interventions: discover tips for PCI without metallic stents, explore novel tools for bifurcation and complex lesions, and learn from clinical experiences in managing long diffused lesions.
PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
